Plunkett Research Online: Grifols SA

GRIFOLS SA (GRFS:NAS) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

Grifols SA develops, manufactures and distributes a broad range of biological medicines on plasma-derived proteins. Plasma derivatives are proteins found in human plasma, which once isolated and purified, have therapeutic value. The firm operates its business in four segments: bioscience, diagnost.....



Grifols SA
Ticker: GRFS
Exchange: NAS
Parent Company:
Year Established:
Employees:
Fiscal Year Ends in

Phone: 34 935710165
Fax: 34 935710267
Address: Avinguda de la Generalitat, 152-158
Parque empresarial Can Sant Joan
Sant Cugat del Vallès
Barcelona, 08174 Spain

Types Of Business
Industry Ranks

Industry NAICS code:

Biotherapeutics Research, Development & Manufacturing
Plasma Derivatives
Diagnostics
ContactsDescription
Peter AllenCEO, Subsidiary/President, Divisional
Gregory RichCEO, Subsidiary/President, Subsidiary
See More
Grifols SA develops, manufactures and distributes a broad range of biological medicines on plasma-derived proteins. Plasma derivatives are proteins found in human plasma, which once isolated and purified, have therapeutic value. The firm operates its business in four segments: bioscience, diagnost.....See More See More

Auditor: KPMG Auditores, S.L.
Legal Advisor:
$USD, In whole numbers,
except marked * or %
201720162015201420132012
Financials
    Revenue
    Cost of Revenue
    Gross Margin %
    R&D Expense
    Operating Income
    Operating Margin %
    SGA Expense
    Net Income
    Earnings Per Share
    Dividends
    Book Value Per Share
    Operating Cash Flow
    Capital Expenditure
    Free Cash Flow
Profitability
    EBITDA
    Return on Assets %
    Return on Equity %
    Net Margin %
    Assets Turnover
    Financial Leverage
Brands, Divisions and AffiliatesTop Salaries
Grifols Engineering SA
Other ThoughtsCorporate Culture

Apparent Female Officers or Directors: